首页 | 本学科首页   官方微博 | 高级检索  
     

TK1、Ki-67在非小细胞肺癌组织中的表达及预后意义
引用本文:冯 蕾,饶 秋,刘 标,樊祥山,石永利,孟凡青,冯振卿. TK1、Ki-67在非小细胞肺癌组织中的表达及预后意义[J]. 南京医科大学学报(自然科学版), 2012, 0(7): 983-988
作者姓名:冯 蕾  饶 秋  刘 标  樊祥山  石永利  孟凡青  冯振卿
作者单位:南京医科大学病理学系,江苏 南京 210029;泰州职业技术学院医学技术学院,江苏 泰州 225300;南京军区南京总医院病理科,江苏 南京 210002;南京军区南京总医院病理科,江苏 南京 210002;南京大学医学院附属鼓楼医院病理科,江苏 南京 210008;南京医科大学病理学系,江苏 南京 210029;南京大学医学院附属鼓楼医院病理科,江苏 南京 210008;南京医科大学病理学系,江苏 南京 210029
基金项目:江苏省卫生厅科研基金(H200938)
摘    要:目的:探讨细胞质胸苷激酶1(thymidine kinase 1,TK1)和Ki-67在非小细胞肺癌(non-small cell lung cancer,NSCLC)中的表达水平及其对NSCLC患者预后的意义?方法:将202例NSCLC及63例癌旁肺组织标本制作成组织芯片,采用免疫组织化学EnVision法检测TK1和Ki-67的表达,探讨其表达水平与临床病理特征及预后的关系?结果:NSCLC组织中TK1(60.89%)和Ki-67(55.45%)的阳性表达率均显著高于癌旁肺组织(P < 0.01);Spearman等级相关分析显示二者的表达呈正相关(r = 0.518, P < 0.001);NSCLC中,TK1和Ki-67的表达均与肿瘤分化程度和TNM分期显著相关(P < 0.05);Kaplan-Meier生存分析显示随TK1表达的增强和Ki-67指数的增高,NSCLC患者的总体生存期逐渐降低(P < 0.01);Cox 回归分析提示肿瘤TK1表达和TNM分期是影响NSCLC患者预后的独立危险因素(P < 0.05)?结论:TK1在NSCLC的表达与肿瘤的分化?进展有关,TK1表达有助于对患者预后的评价?

关 键 词:细胞质胸苷激酶1   Ki-67   非小细胞肺癌   组织芯片   预后
收稿时间:2012-03-06

The expression and prognostic significance of TK1 and Ki-67 in non-small cell lung cancer
FENG Lei,RAO Qiu,LIU Biao,FAN Xiang-shan,SHI Yong-li,MENG Fan-qing and FENG Zhen-qing. The expression and prognostic significance of TK1 and Ki-67 in non-small cell lung cancer[J]. Acta Universitatis Medicinalis Nanjing, 2012, 0(7): 983-988
Authors:FENG Lei  RAO Qiu  LIU Biao  FAN Xiang-shan  SHI Yong-li  MENG Fan-qing  FENG Zhen-qing
Affiliation:Department of Pathology,NJMU,Nanjing 210029;School of Medicine Technology,Taizhou Polytechnic College,Taizhou 225300;Department of Pathology,Nanjing General Hospital of Nanjing Military Command,Nanjing 210002;Department of Pathology,Nanjing General Hospital of Nanjing Military Command,Nanjing 210002;Department of Pathology,Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University,Nanjing 210008,China;Department of Pathology,NJMU,Nanjing 210029;Department of Pathology,Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University,Nanjing 210008,China;Department of Pathology,NJMU,Nanjing 210029
Abstract:Objective:To investigate the expressions of thymidine kinase 1(TK1) and Ki-67 in non-small cell lung cancer(NSCLC)and their prognostic value in NSCLC. Methods:The tissue microarrays which contain 202 NSCLC cases and 63 normal lung cases were constructed. The expressions of TK1 and Ki-67 were detected in these tissues by immunohistochemistry method. The relationship between expression levels of two makers and the clinicopathological and survival parameters of NSCLC were evaluated. Results:The positive expression rates of TK1(60.89%)and Ki-67(55.45%)in the NSCLC tissues were significantly higher than those in normal tissue group (P < 0.000 1,P < 0.000 5). The Spearman correlation analysis showed that the expression of TK1 were positively correlated with Ki-67 expression (r = 0.518,P < 0.001). In the group of NSCLC, both TK1 and Ki-67 expression were significant correlated with tumor grade and TNM stage. Kaplan-Meier survival analysis indicated that the survival rate was markedly lower in patients with high expression level of two markers than those with low expression level (P < 0.05);Multivariate analysis using Cox regression model identified that TNM stage and TK1 expression were independent prognostic factors of NSCLC (P < 0.05). Conclusion:The expression of TK1 was significantly correlated with tumor grade and TNM stage. TK1 might be employed to evaluate the prognosis of NSCLC patients.
Keywords:thymidine kinase 1  Ki-67  non-small cell lung cancer  tissue microarray  prognosis
点击此处可从《南京医科大学学报(自然科学版)》浏览原始摘要信息
点击此处可从《南京医科大学学报(自然科学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号